Anthracycline versus nonanthracycline adjuvant therapy for early breast cancer: A systematic review and meta-analysis

AbstractPurpose:The clinical benefits provided by using anthracycline-contained regimens in patients with early breast cancer (EBC) remain uncertain. This meta-analysis used data from all relevant trials to compare treatment outcomes for patients with EBC receiving adjuvant chemotherapy with non–ant